PCVX

NASDAQ · Biotechnology

Vaxcyte Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$58.07

-0.82 (-1.39%)

As of Aug 8, 1:18 AM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 88%

Hold 2 12%

Sell 0 0%

Price Target

Analyst Price Target +15.5% upside

Low Target $56.09

Average Target $67.08

High Target $108.72

Current Price $58.07

Current
$58.07

Target
$67.08

$56.09 $67.08 avg $108.72

Scenario Analysis

Bear Case

$56.09

-3.4%

Low target

Base Case

$67.08

+15.5%

Avg target

Bull Case

$108.72

+87.2%

High target

Risk/Reward

25.6x

Highly favorable

Price in Context

52-Week High

$65.00

-10.7% from high

52-Week Low

$29.08

+99.7% from low

50-Day SMA

$49.46

+17.4% vs SMA

200-Day SMA

$39.88

+45.6% vs SMA

RSI (14)

62.6

Neutral

Target vs 52W High

$67.08

+3.2% vs high

Next Earnings Report

Aug 12, 2026

until earnings

EPS Est: $-2.10

Earnings in 3 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%